Stories written by

Dinesh Thakur

Pharmaceutical sector: Why India needs a regulatory pathway for biosimilar drugs

Without this, the poor and hapless patients will need to pay more for medicine.

Dinesh Thakur
&
Prashant Reddy T
· Mar 07, 2024 · 09:00 am
The Jan Vishwas bill passed by Lok Sabha further dilutes the regulation of pharmacies

Dispensing drugs is often a question of life and death for patients, but pharmacies brazenly violate laws governing the employment of pharmacists.

Dinesh Thakur
&
Prashant Reddy T
· Aug 02, 2023 · 07:30 am
India’s drug approval system is broken but a proposed new law does nothing to fix it

Despite the Drugs Controller General of India having functioned in a whimsical and opaque manner, the draft bill does not curb its vast discretionary powers.

Dinesh Thakur
&
Prashant Reddy T
· Aug 06, 2022 · 09:00 am

Video

See all

A new class of drugs is here – but India is dangerously inept at dealing with them

There is serious doubt over the competence of India’s regulatory regime for biosimilar drugs. If this isn't fixed soon, the biggest losers will be Indian patients.

Dinesh Thakur
· Sep 16, 2015 · 09:00 am

Dinesh Thakur

Pharmaceutical sector: Why India needs a regulatory pathway for biosimilar drugs

Without this, the poor and hapless patients will need to pay more for medicine.

Dinesh Thakur
&
Prashant Reddy T
· Mar 07, 2024 · 09:00 am

The Jan Vishwas bill passed by Lok Sabha further dilutes the regulation of pharmacies

Dispensing drugs is often a question of life and death for patients, but pharmacies brazenly violate laws governing the employment of pharmacists.

Dinesh Thakur
&
Prashant Reddy T
· Aug 02, 2023 · 07:30 am

India’s drug approval system is broken but a proposed new law does nothing to fix it

Despite the Drugs Controller General of India having functioned in a whimsical and opaque manner, the draft bill does not curb its vast discretionary powers.

Dinesh Thakur
&
Prashant Reddy T
· Aug 06, 2022 · 09:00 am

Getting clinical practice guidelines right is crucial for India to control the pandemic

Equally, getting them wrong could lead to damaging consequences.

Jammi Nagaraj Rao
&
Dinesh Thakur
· May 30, 2021 · 09:00 am

Which public authority should be in charge of India’s policy on diagnostic kits for Covid-19?

It is important for the Central government to clearly delineate responsibilities as per the constitutional framework.

Dinesh Thakur
&
Prashant Reddy T
· Apr 03, 2020 · 07:30 am

Why the Indian Supreme Court’s judgment on combination drugs sends wrong signals

It indicates to High Courts that judges can sidestep the legislative procedures on complex regulatory issues if these are deemed inconvenient.

Dinesh Thakur
&
Prashant Reddy T
· Dec 29, 2017 · 02:30 pm

Video

Eco India: How climate resilient fox nuts are helping Bihar's farmers tackle crop losses

Nov 17, 2024 · 08:55 am

Eco India, Episode 274: How worsening environmental conditions call for action and innovation

Nov 16, 2024 · 03:25 pm

Eco India: Kanpur's tanneries adopt sustainable practices to cut environmental impact

Nov 10, 2024 · 08:55 am

Eco India, Episode 273: How cleaner alternatives pave way for a sustainable future

Nov 09, 2024 · 03:25 pm

Watch: Crises of belonging and citizenship in Assam

Nov 07, 2024 · 03:30 pm

A new class of drugs is here – but India is dangerously inept at dealing with them

There is serious doubt over the competence of India’s regulatory regime for biosimilar drugs. If this isn't fixed soon, the biggest losers will be Indian patients.

Dinesh Thakur
· Sep 16, 2015 · 09:00 am

Dinesh Thakur

Pharmaceutical sector: Why India needs a regulatory pathway for biosimilar drugs

Without this, the poor and hapless patients will need to pay more for medicine.

Dinesh Thakur & Prashant Reddy T · Mar 07, 2024 · 09:00 am

The Jan Vishwas bill passed by Lok Sabha further dilutes the regulation of pharmacies

Dispensing drugs is often a question of life and death for patients, but pharmacies brazenly violate laws governing the employment of pharmacists.

Dinesh Thakur & Prashant Reddy T · Aug 02, 2023 · 07:30 am

India’s drug approval system is broken but a proposed new law does nothing to fix it

Despite the Drugs Controller General of India having functioned in a whimsical and opaque manner, the draft bill does not curb its vast discretionary powers.

Dinesh Thakur & Prashant Reddy T · Aug 06, 2022 · 09:00 am

Trending

Not stubble burning, cars are the main villain in Delhi's apocalyptic air pollution

10 hours ago

Why the US has accused Adani of hiding its alleged bribes in India from American investors

3 hours ago

How a British suffragist brought Ajanta’s ancient paintings into the light of modernity

Nov 19, 2024 · 11:30 am

‘Chikkamma Tours Pvt Ltd’: A cosy Bangalore murder mystery with a realistic portrayal of queer lives

Nov 17, 2024 · 05:30 pm

US charges Gautam Adani in alleged $265 million bribery, fraud case

9 hours ago

Getting clinical practice guidelines right is crucial for India to control the pandemic

Equally, getting them wrong could lead to damaging consequences.

Jammi Nagaraj Rao & Dinesh Thakur · May 30, 2021 · 09:00 am

Which public authority should be in charge of India’s policy on diagnostic kits for Covid-19?

It is important for the Central government to clearly delineate responsibilities as per the constitutional framework.

Dinesh Thakur & Prashant Reddy T · Apr 03, 2020 · 07:30 am

Why the Indian Supreme Court’s judgment on combination drugs sends wrong signals

It indicates to High Courts that judges can sidestep the legislative procedures on complex regulatory issues if these are deemed inconvenient.

Dinesh Thakur & Prashant Reddy T · Dec 29, 2017 · 02:30 pm

Video

Eco India: How climate resilient fox nuts are helping Bihar's farmers tackle crop losses

Nov 17, 2024 · 08:55 am

Eco India, Episode 274: How worsening environmental conditions call for action and innovation

Nov 16, 2024 · 03:25 pm

Eco India: Kanpur's tanneries adopt sustainable practices to cut environmental impact

Nov 10, 2024 · 08:55 am

Eco India, Episode 273: How cleaner alternatives pave way for a sustainable future

Nov 09, 2024 · 03:25 pm

Watch: Crises of belonging and citizenship in Assam

Nov 07, 2024 · 03:30 pm

A new class of drugs is here – but India is dangerously inept at dealing with them

There is serious doubt over the competence of India’s regulatory regime for biosimilar drugs. If this isn't fixed soon, the biggest losers will be Indian patients.

Dinesh Thakur · Sep 16, 2015 · 09:00 am

Take Scroll With You

Dinesh Thakur
&
Prashant Reddy T
· Mar 07, 2024 · 09:00 am

Dinesh Thakur
&
Prashant Reddy T
· Aug 02, 2023 · 07:30 am

Dinesh Thakur
&
Prashant Reddy T
· Aug 06, 2022 · 09:00 am

Jammi Nagaraj Rao
&
Dinesh Thakur
· May 30, 2021 · 09:00 am

Dinesh Thakur
&
Prashant Reddy T
· Apr 03, 2020 · 07:30 am

Dinesh Thakur
&
Prashant Reddy T
· Dec 29, 2017 · 02:30 pm

Dinesh Thakur
· Sep 16, 2015 · 09:00 am